Stratified medicine in rheumatology
Stratified medicine approaches are based on the concept that different subgroups (often referred to as “endotypes” or “pathotypes) exist within a single disease entity. There is a substantial level of heterogeneity within individual Rheumatic and Musculoskeletal Diseases (RMDs) suggesting that stratified medicine approaches are not only feasible but will become an essential part of a more specific and better management of these diseases.
FOREUM instigated a call for research proposal to support projects in the following areas:
- Studies that support the definition of distinct molecular endotypes of RMDs differing in clinical presentation, disease course or outcome
- Development and validation of predictors of disease outcome (prognostic biomarkers)
- Development and validation of biomarkers that allow better prediction of response to anti-rheumatic drugs
- Innovative methodological approaches to the study of stratified medicine
- Applications demonstrating the value of genetic, biochemical and imaging biomarkers in a stratified medicine approach.
24 letters of intent were received, peer reviewed and thoroughly evaluated. As a result, two projects are being funded.
Stratified medincine in primary Sjögren's syndrome
Go to project
Molecular stratification in GCA
Go to project